Page last updated: 2024-10-22

amobarbital and Dysphagia

amobarbital has been researched along with Dysphagia in 1 studies

Amobarbital: A barbiturate with hypnotic and sedative properties (but not antianxiety). Adverse effects are mainly a consequence of dose-related CNS depression and the risk of dependence with continued use is high. (From Martindale, The Extra Pharmacopoeia, 30th ed, p565)
amobarbital : A member of the class of barbiturates that is pyrimidine-2,4,6(1H,3H,5H)-trione substituted by a 3-methylbutyl and an ethyl group at position 5. Amobarbital has been shown to exhibit sedative and hypnotic properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19901 (100.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Geffen, G1
Traub, E1
Stierman, I1

Other Studies

1 other study available for amobarbital and Dysphagia

ArticleYear
Language laterality assessed by unilateral ECT and dichotic monitoring.
    Journal of neurology, neurosurgery, and psychiatry, 1978, Volume: 41, Issue:4

    Topics: Adolescent; Adult; Amobarbital; Auditory Perception; Child; Deglutition Disorders; Depression; Domin

1978